It has been hailed as a game‑changing moment for slimmers. Earlier this month, a new pill form of Wegovy – the blockbuster weight‑loss jab – was approved for use in the UK.
It contains semaglutide, the same appetite‑suppressing ingredient used in the injection – part of a new wave of treatments, alongside Mounjaro, that have transformed weight loss.
Take‑up of the Wegovy pill, as it’s known, is expected to be monumental, with recent polling suggesting that twice as many patients would be willing to take a weight‑loss tablet as the injections. Already, online pharmacies that plan to sell the drug say they
To provide well-rounded coverage and a breadth of insight across various events, we rely on contributions from several staff writers, each bringing their own area of expertise to our publication.
